The chemical class of BCLAF1 Activators comprises a range of compounds that could potentially influence the activity of BCLAF1 indirectly. BCLAF1 is integral to several cellular processes, including apoptosis, gene transcription, and the DNA damage response. The modulation of BCLAF1 is closely linked to cellular stressors, DNA damage signals, and apoptotic signals.
Compounds such as Doxorubicin, Etoposide, and Cisplatin, which are known to induce DNA damage, demonstrate their potential to influence BCLAF1 activity through DNA damage response pathways. These agents, by causing DNA strand breaks and replication stress, represent mechanisms through which the expression and function of BCLAF1 can be modulated. Similarly, Hydroxyurea and Camptothecin, which affect DNA synthesis and topoisomerase activity respectively, could also play a role in modulating BCLAF1 activity through their effects on DNA damage and repair mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
A chemotherapeutic agent, could induce DNA damage response, potentially influencing BCLAF1 activity. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Causes DNA strand breaks, might indirectly affect BCLAF1 through DNA damage pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates various signaling pathways, could influence BCLAF1 activity related to apoptosis and stress response. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Affects various signaling pathways, potentially modulating BCLAF1 activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Inhibits DNA synthesis, potentially affecting BCLAF1 activity through DNA damage and replication stress. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Induces DNA damage, could influence BCLAF1 activity through DNA damage response pathways. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $33.00 $73.00 $265.00 $112.00 | 34 | |
Modulates oxidative stress, potentially influencing BCLAF1 activity through redox balance mechanisms. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Regulates gene expression, might indirectly affect BCLAF1 expression and function. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Influences gene expression and cellular signaling, potentially affecting BCLAF1. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, potentially affecting BCLAF1 through DNA damage response. |